Related Experiment Videos

[Pharmacological action on antiviral resistance in patients with acute pneumonia]

Vrachebnoe Delo
|October 1, 1991
PubMed

Insights

Acute pneumonia is linked to reduced monocyte function, impacting phagocytosis and antiviral resistance. Leucocytic interferon boosts phagocytosis, while antibiotics may decrease it and increase virus-involved cells.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cell Biology

Background:

  • Acute pneumonia development is associated with impaired monocyte functional activity.
  • This impairment includes reduced phagocytic capacity and inhibited cellular antiviral resistance.

Purpose of the Study:

  • To investigate the role of monocyte functional activity in acute pneumonia.
  • To evaluate the effects of leucocytic interferon and antibiotics on immune responses in pneumonia patients.

Main Methods:

  • Study involved 30 patients diagnosed with acute pneumonia.
  • Monocyte functional activity, phagocytosis, and antiviral resistance were assessed.
  • Effects of leucocytic interferon and antibiotic treatment on these parameters were observed.

Main Results:

  • Reduced functional activity of monocytes, particularly phagocytosis, was observed in acute pneumonia.
  • Unspecific cellular antiviral resistance was also inhibited.
  • Leucocytic interferon demonstrated a significant activation of phagocytosis.
  • Antibiotic treatment led to a decrease in phagocytic cells and activity, and an increase in virus-involved immunocompetent cells.

Conclusions:

  • Disorders in monocyte functional activity, including phagocytosis and antiviral resistance, are central to acute pneumonia pathogenesis.
  • Leucocytic interferon shows potential in enhancing phagocytic activity.
  • Antibiotics may negatively impact cellular immune responses in pneumonia, warranting further investigation.

Related Concept Videos